Balchem BCPC Incentive stock program, shares reserved for future grants (in shares)

Incentive stock program, shares reserved for future grants (in shares) at other companies

AbbottABT

——

Merck & Co.MRK

——

Other financials

Income statement

See full

Revenue$270.7M+8.1%

Gross profit$101.1M+14.6%

Operating income$55.6M+9.0%

Net income$40.3M+8.7%

EPS (diluted)$1.25+10.6%

Balance sheet

See full

Cash & equivalents$72.9M+46.0%

Total debt$37.4M-1.7%

Total equity$1.3B+6.3%

Total assets$1.7B+4.7%

Cash flow

See full

Operating cash flow$40.1M+9.9%

Valuation

See full

Market cap$5.33B+0.5%

Enterprise value$5.3B+0.1%

P/E33.7×-5.1×

P/S5×-0.5×

Profitability

See full

Gross margin36.3%+0.7pp

Operating margin20.2%+0.3pp

Net margin15%+0.8pp

FCF margin14.9%—

Returns & leverage

See full

Return on equity12.7%+0.7pp

Debt / equity0×0.0×

Current ratio2.5×+0.1×

Where this comes from

Reported directly by Balchem in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.

The official record: Balchem’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Balchem's incentive stock program, shares reserved for future grants (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Balchem's incentive stock program, shares reserved for future grants (in shares)?: Balchem (BCPC) reported incentive stock program, shares reserved for future grants (in shares) of $503.57K in Q1 2026.
How has Balchem's incentive stock program, shares reserved for future grants (in shares) changed year-over-year?: Balchem's incentive stock program, shares reserved for future grants (in shares) decreased by 26.5% year-over-year, from $685.59K to $503.57K.